A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer

被引:2
|
作者
Kasi, P. M. [1 ]
Sawyer, S. [2 ]
Guilford, J. [2 ]
Munro, M. [2 ]
Ellers, S. [2 ]
Hook, N. [2 ]
Krinshpun, S. [2 ]
Moshkevich, S. [2 ]
Billings, P. R. [2 ]
Aleshin, A. [2 ]
机构
[1] Univ Iowa Hlth Care, Internal Med, Iowa City, IA USA
[2] Natera Inc, Oncol, San Carlos, CA USA
关键词
D O I
10.1016/j.annonc.2020.08.630
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
520TiP
引用
收藏
页码:S459 / S459
页数:1
相关论文
共 50 条
  • [21] Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
    Gong Chen
    Junjie Peng
    Qian Xiao
    Hao-Xiang Wu
    Xiaojun Wu
    Fulong Wang
    Liren Li
    Peirong Ding
    Qi Zhao
    Yaqi Li
    Da Wang
    Yang Shao
    Hua Bao
    Zhizhong Pan
    Ke-Feng Ding
    Sanjun Cai
    Feng Wang
    Rui-Hua Xu
    Journal of Hematology & Oncology, 14
  • [22] Negative prognostic impact of tumor deposits in stage III colorectal cancer patients
    Ma, Ting
    Qin, Zhaofu
    Xu, Guohui
    Zheng, Peng-Wen
    Feng, Longhai
    Ma, Dening
    Fu, Zhixuan
    Gao, Xinyi
    PLOS ONE, 2024, 19 (09):
  • [23] Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (07): : 481 - 481
  • [24] Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
    Tie, Jeanne
    Cohen, Joshua D.
    Lahouel, Kamel
    Lo, Serigne N.
    Wang, Yuxuan
    Kosmider, Suzanne
    Wong, Rachel
    Shapiro, Jeremy
    Lee, Margaret
    Harris, Sam
    Khattak, Adnan
    Burge, Matthew
    Harris, Marion
    Lynam, James
    Nott, Louise
    Day, Fiona
    Hayes, Theresa
    McLachlan, Sue-Anne
    Lee, Belinda
    Ptak, Janine
    Silliman, Natalie
    Dobbyn, Lisa
    Popoli, Maria
    Hruban, Ralph
    Lennon, Anne Marie
    Papadopoulos, Nicholas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Tomasetti, Cristian
    Gibbs, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2261 - 2272
  • [25] Circulating tumor DNA and recurrence risk in stage II-III gastric cancer.
    Yuan, Shu-Qiang
    Huang, You-Sheng
    Nie, Run-Cong
    Chen, Yingbo
    Wang, Si-Yu
    Sun, Xiaowei
    Li, Yuanfang
    Liu, Ze-Kun
    Chen, Yan-Xing
    Yao, Yi-Chen
    Xu, Yu
    Qiu, Haibo
    Liang, Yao
    Wang, Wei
    Zhou, Zhiwei
    Xu, Rui-Hua
    Wang, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
  • [27] Use of circulating tumor DNA in colorectal cancer patients to assess tumor burden and response to therapy: An observational study.
    Symonds, Erin L.
    Pedersen, Susanne Kartin
    Yeo, Bernita Hui Li
    Al Naji, Hiba
    Byrne, Susan E.
    Roy, Amitesh Chandra
    Young, Graeme P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [28] A clinical validation study to predict recurrence in stage II-III colorectal cancer (CRC) using a bespoke circulating tumor DNA (ctDNA) assay to detect molecular residual disease (MRD): The CORRECT-MRD I study
    Srinivasan, G.
    Hubert, A.
    Purim, O.
    Semenisty, V.
    Lo, N.
    Tsukada, Y.
    Mondello, G.
    Cubillo, A.
    Subramaniam, S.
    Palomares, M. R.
    Baehner, R. F. L.
    De Jong, F.
    Kerr, D. J.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S69 - S70
  • [29] Circulating tumor DNA (ctDNA) to evaluate stage III and stage IV metastatic breast cancer (MBC), describe tumor heterogeneity, and outcome.
    Zhang, Qiang
    Cai, Zheng
    Gerratana, Lorenzo
    Davis, Andrew A.
    Jacob, Saya
    D'Amico, Paolo
    Vagia, Elena
    Zhang, Youbin
    Qiang, Wenan
    Wehbe, Firas
    Kerby, Katy Lucretia
    Flaum, Lisa E.
    Shah, Ami N.
    Behdad, Amir
    Gradishar, William John
    Platanias, Leonidas C.
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Impact of circulating tumor DNA on clinical decisions in the adjuvant setting in patients with colorectal cancer
    Wookey, V.
    Mehler, S.
    Stein, M.
    Grothey, A.
    Norton, A.
    Somer, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S139 - S139